« Back
Home /
Nimodipine

Nimodipine

€91.00

Excl. VAT

Item no.	HY-B0265-500mg
Manufacturer	MedChem Express
CASRN	66085-59-4
Amount	500 mg
Category	Cardiovascular Research Myocardial Infarction Hypertension Inhibitors & Compound Libraries Small Molecules Arrhythmias
Type	Inhibitors
Clone	N/A
Specific against	other
Purity	99.86
Formula	C21H26N2O7
Citations	[1]Langley, M.S., et al. Nimodipine. Drugs 37, 669–699 (1989). [2] Marbacher S, et al. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med. 2008;34(5):932-938. [3]Honn KV, et al. Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine. Clin Exp Metastasis. 1984;2(1):61-72.
Smiles	O=C(C1=C(C)NC(C)=C(C(OC(C)C)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OCCOC
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BAY-e 9736
Available
Product Description	Nimodipine (BAY-e 9736) is an orally active, well-tolerated and light-sensitive dihydropyridine calcium antagonist. Nimodipine can be used for the research of cerebrovascular disorders[1].
StorageTemperature	4°C (Powder, protect from light)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
Molecular Weight	418.44
Clinical Information	Launched
Solubility	DMSO : 100 mg/mL (ultrasonic)
Pathway	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0265-500mg-safety-datasheet.pdf